ஆண்ட்ரியா னேக்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆண்ட்ரியா னேக்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆண்ட்ரியா னேக்சி Today - Breaking & Trending Today

UroToday - The Global Online Community of Urologists

UroToday - The Global Online Community of Urologists
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

United States , New Zealand , Andrewj Armstrong , Andrew Armstrong , Michaelj Morris , Ian Davis , David Cella , Arun Azad , Brian Rini , Tamim Niazi , Briani Rini , Daniel George , Thomas Powles , Andrea Necchi , Danielj George , Micheal Morris , Ben Tran , Silke Gillessen , Lawrence Mbuagbaw , Cora Sternberg , Lisa Horvath , Coran Sternberg , Yohann Loriot , Cancer Trials Group , European Multidisciplinary Congress On Urological Cancers , Tamer Khashab ,

Promising Early Data for Bladder-Sparing Cancer Treatment

Bladder-intact DFS at 1 year nears 90% for muscle-invasive bladder cancer ....

New York , United States , Andrea Necchi , Charles Bankhead , Arjunv Balar , Langone Health , American Society Of Clinical Oncology , Salute San Raffaele University , New York City , American Society , Clinical Oncology , Vita Salute San Raffaele University , Medpage Today , Bladder Cancer , Maculopapular Rash , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஆண்ட்ரியா னேக்சி , சார்லஸ் வங்கித் தலை , லன்கொனே ஆரோக்கியம் , அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல் , வணக்கம் சான் ராப்பஆேழே பல்கலைக்கழகம் , புதியது யார்க் நகரம் , அமெரிக்கன் சமூகம் , மருத்துவ புற்றுநோயியல் , வீடா வணக்கம் சான் ராப்பஆேழே பல்கலைக்கழகம் ,

Testicular, Penile, and Rare GU Malignancies

Testicular, Penile, and Rare GU Malignancies
Interviews with Experts at Conferences
Curated by clinicians: educational forums with videos, abstracts and conference information
Videos
April 27, 2021
The State-of-the-Evidence in Brief Reviews by Experts
May 17, 2021
Penile cancer (PC) is a rare malignancy with an incidence estimated less than 1/100 000 per year in the Western World
1-3
Historically, demolitive surgical approaches, such as total or partial penile amputation, were the most commonly used. Indeed, demolitive options were deemed to be necessary in order to respect a macroscopic surgical margin of at least 2 cm.
3-4 If the oncological outcomes of these approaches demonstrated to be satisfactory, they significantly affected aesthetic outcomes, as well as sexual and urinary functions. ....

United States , New Zealand , Julien Van Damme , Pilar Laguna , Christopher Jd Wallis , Fallen James , Zachary Klaassen , Philippe Spiess , Darren Feldman , Andrea Necchi , Lucia Nappi , Philippee Spiess , Lyndal Moore , James Lynam , Silke Gillessen , Peter Albers , Alok Tewari , Andreas Hiester , Patricia Bastick , European Association Of Urology , European Multidisciplinary Congress On Urological Cancers , Moffitt Cancer Center , Global Society Of Rare Genitourinary Tumors , Cancer Trials Group , International Germ Cell Cancer Collaborative Group , Virtual Annual Congress ,

EMUC 2020: Neoadjuvant Versus Adjuvant Strategies in Locally Advanced Bladder Cancer

EMUC 2020: Neoadjuvant Versus Adjuvant Strategies in Locally Advanced Bladder Cancer
(UroToday.com) In an oral presentation in a session examining neoadjuvant versus adjuvant strategies in locally advanced bladder cancer at the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Andrea Necchi led a discussion of neoadjuvant strategies in advanced bladder cancer.
He began highlighting muscle invasive bladder cancer (MIBC) as a model for clinical research based on high rates of relapse and mortality following surgical intervention alone, the relatively poor use of neoadjuvant chemotherapy in spite of international guidelines, the poor prognosis of patients with residual MIBC following neoadjuvant chemotherapy, and the uncertainty of treatment approaches in patients who are ineligible for cisplatin. ....

Christopher Jd Wallis , Neoadjuvant Pembrolizumab , Andrea Necchi , European Multidisciplinary Congress On Urological Cancers , Vanderbilt University Medical Center , European Multidisciplinary Congress , Urological Cancers , Muscle Invasive Urothelial Bladder Carcinoma , Neo Adjuvant Bladder Urothelial Carcinoma , Medical Oncologist , Italy Written , Urologic Oncology Fellow , கிறிஸ்டோபர் ஜ்ட் வாலிஸ் , ஆண்ட்ரியா னேக்சி , ஐரோப்பிய பலதரப்பட்ட காங்கிரஸ் ஆன் சிறுநீரக புற்றுநோய்கள் , வாண்டர்பில்ட் பல்கலைக்கழகம் மருத்துவ மையம் , ஐரோப்பிய பலதரப்பட்ட காங்கிரஸ் , சிறுநீரக புற்றுநோய்கள் , மருத்துவ புற்றுநோயியல் நிபுணர் , இத்தாலி எழுதப்பட்டது , சிறுநீரக புற்றுநோயியல் சக ,

GSRGT 2020: Evolution of Systemic Therapies and the Landscape of Clinical Trials Enrolling Patients

GSRGT 2020: Evolution of Systemic Therapies and the Landscape of Clinical Trials Enrolling Patients
(UroToday.com) To discuss the evolution of systemic therapies and the landscape of clinical trials among patients with penile cancer, Dr. Philippe Spiess, the co-Course Director of the Global Society of Rare Genitourinary Tumors (GSRGT) 2020 Virtual Summit, invited Dr. Jad Chahoud, his colleague from the Moffitt Cancer Center.
Dr. Chahoud started by highlighting that penile cancer is a rare disease in the US, representing 0.7% of all cancer, with high-risk HPV responsible for ~50% of all penile squamous cell carcinoma. The majority of these patients will present with localized or locally advanced disease whereby platinum-based combination chemotherapy remains the front-line therapy. The InPACT trial is actively enrolling patients to determine the frontline therapy for locally advanced penile cancer, given there have been limited treatment advancements in the last decade. ....

United States , Patrizia Giannatempo , Zachary Klaassen , Daniele Raggi , Andrea Necchi , Philippe Spiess , Michaelb Williams , Sijin Wen , Curtisa Pettaway , William Osai , Nicola Nicolai , Danai Daliani , Giuseppina Calareso , Michael Kincaid , Bju International , Augusta University Medical College Of Georgia , Moffitt Cancer Center , Global Society Of Rare Genitourinary Tumors , Department Of Genitourinary Oncology , Georgia Cancer Center , National Comprehensive Cancer Network , Course Director , Global Society , Rare Genitourinary Tumors , Jad Chahoud , Moffitt Cancer ,